DoW Autism Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 21, 2026
- Amount
- Program total $2.3M
- Closes
- Oct 22, 2026 (in 45 days)
Similar opportunities open now
- DoW Autism Career Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 45 days
- DoW Autism Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 45 days
- DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 23 days
- DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 23 days
- DoW Arthritis Clinical Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 45 days
Classification and identifiers
- Solicitation number
- HT942526ARPIDA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $2.3M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for Autistic individuals. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. Distinctive Features: Applications are strongly encouraged to address one of the FY26 ARP Idea Development Award Areas of Interest or provide justification that the proposed research addresses a critical problem, question, or need in autism. Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each o...